Trial
NCT04510844
Evolocumab In Advanced Chronic Kidney Disease Trial
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
Chronic Kidney Diseases
Intervention
Evolocumab
Why stopped
loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-28